Replies to post #217059 on Cytodyn Inc (CYDY)

[Monroe1]

So yes, could it be Roche, Regeneron, Merck or another company that our management team and Scientific Advisory Board have working relationships with past and present???

The sales of our securities over in Germany is quite interesting. I think some group is acquiring shares. Could the cleaning up of residual unsold shares as seen in Fridays Amendment statements de-registering unsold portions end up "helping" an undisclosed foreign accumulator of unregistered stock?

The above, plus the revamping of prior note and the $7.9 million raised in January shows Cyrus and team are definitely focused on something big. In any event, he served as co-founder and managing partner of BioVega Capital LLC, a life sciences hedge fund. Clearly, the tell-tale signs of advancement are definitely in line with a focused strategy. $CYDY$